| human | Q5 |
| P496 | ORCID iD | 0000-0002-8969-2378 |
| P69 | educated at | University of Nottingham | Q472316 |
| London School of Hygiene & Tropical Medicine | Q1126189 | ||
| P108 | employer | Institute of Cancer Research | Q6039999 |
| P734 | family name | Brook | Q16860536 |
| Brook | Q16860536 | ||
| Brook | Q16860536 | ||
| P735 | given name | Mark | Q13610143 |
| Mark | Q13610143 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q89506041 | Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q56089359 | Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q62583499 | Breast Cancer Risk After Recent Childbirth |
| Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
| Q62583503 | Comparative validation of breast cancer risk prediction models and projections for future risk stratification |
| Q92150094 | Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q91685253 | Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel |
| Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q64074106 | Homeobox B13 G84E Mutation and Prostate Cancer Risk |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q39006395 | Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer |
| Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q62583659 | Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q99561517 | Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q44903190 | Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study |
| Q38370371 | The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium |
| Q89547730 | iCARE: An R package to build, validate and apply absolute risk models |
Search more.